Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Royal Pharmaceutical Society

Association, Washington, D.C. and The Phamiaceutical Press, Royal Pharmaceutical Society, London, 1994, pp. 500—505. [Pg.7]

Table 2.1 HPLC capacity factors for secbuto-barbitone and vinbarbitone with an octadecyl silyl stationary phase and mobile phases of methanoiyO.l M sodium dihydrogen phosphate (40 60) at (a) pH 3.5, and (b) pH 8.5. From Moffat, A.C. (Ed.), Clarke s Isolation and Identification of Drugs, 2nd Edn, The Pharmaceutical Press, London, 1986. Reproduced by permission of The Royal Pharmaceutical Society... Table 2.1 HPLC capacity factors for secbuto-barbitone and vinbarbitone with an octadecyl silyl stationary phase and mobile phases of methanoiyO.l M sodium dihydrogen phosphate (40 60) at (a) pH 3.5, and (b) pH 8.5. From Moffat, A.C. (Ed.), Clarke s Isolation and Identification of Drugs, 2nd Edn, The Pharmaceutical Press, London, 1986. Reproduced by permission of The Royal Pharmaceutical Society...
Martidale The Extra Pharmacopoeia, 31st edn. (1996) Disinfectants and Preservatives pp. 1111-1149. London The Royal Pharmaceutical Society. (2)... [Pg.373]

Reynolds, J. E. F. Ed., Martindale The Extra Pharmacopoeia, 31sted. The Royal Pharmaceutical Society London, 1996. Martindales Pharmacopeia. [Pg.835]

Aikens JE, Nease Jr DE et aL (2005) Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med 3 23-30 Blenkinsopp A, Bond C, Britten N (1997) From compliance to concordance. Achieving shared goals in medicine taking. Royal Pharmaceutical Society of Great Britain and Merck Sharpe Dome, London UK... [Pg.117]

Royal Pharmaceutical Society (1997) From compliance to concordance towards shared goals in medicine taking. Royal Pharmaceutical Society of Great Britain, London... [Pg.118]

Snell M, ed (2008). Medicines, Ethics and Practice a guide for pharmacists and pharmacy technicians, 32nd rev edn. London Royal Pharmaceutical Society of Great Britain. Sweetman SC, ed (2006). Martindale the Complete Drug Reference, 35th edn. London Pharmaceutical Press. [Pg.343]

Medicines, Ethics and Practice a Guide for Pharmacists and Pharmacy Technicians, 32, July 2008. London Royal Pharmaceutical Society of Great Britain, 2008. [Pg.451]

The Royal Pharmaceutical Society of Great Britain has issued guidance in relation to the acceptance of gifts and inducements to prescribe or supply. The Society states that pharmacists accepting items such as gift vouchers, bonus points, discount holidays, sports equipment etc would be in breach of the Society s Code of Ethics and advises pharmacists not to participate in such offers. [Pg.762]

Methods of sale of medicines through pharmacies are also covered by the Code of Ethics of the Royal Pharmaceutical Society of Great Britain. [Pg.767]

Copies of the published reports are sent to the Medicines and Healthcare products Regulatory Agency, the Office of Fair Trading, the British Medical Association, the Royal Pharmaceutical Society of Great Britain and the Editors of the BMJ and The Pharmaceutical Journal. Copies of the published reports are also available to anyone on request. [Pg.779]

Royal Pharmaceutical Society of Great Britain Code of Ethics ... [Pg.786]

Karen Baxter, BSc, MSc, MRPharmS Editor, Stockley s Drug Interactions Pharmaceutical Press ( Royal Pharmaceutical Society ofGB), I Lambeth High Street, London SEl 7JN, England, UK... [Pg.831]

Martindale, The Extra Pharmacopoeia, 3 U ed.. Royal Pharmaceutical Society, London, 1996, p. 687. [Pg.150]

The Royal Pharmaceutical Society s New Technology Forum (NTF) has continued its discussions on PAT with participation of FDA PAT Team members. [Pg.512]

N. A. Armstrong and co-workers, in A. Wade and P. J. Weller, eds., Handbook of Pharmaceutical Excipients, 2nd ed., American Pharmaceutical Association, Washington, D.C. and The Pharmaceutical Press, Royal Pharmaceutical Society, London, 1994, pp. 500—505. [Pg.7]

Michael J. Groves, a pharmacist with a doctorate in chemical engineering, has spent much of his career working in industry and academe. Now retired, his scientific interests include dispersed drug delivery systems and quality control issues for parenteral drug products. Editor or joint editor of a number of books, he has published 400 research papers, patents, reviews, and book reviews. He is a Fellow of the Royal Pharmaceutical Society of Great Britain, the Institute of Biology, and the American Association of Pharmaceutical Scientists. [Pg.403]

Antimuscarinic Agents (1996) In Reynolds JEF (ed.) Martindale the extra pharmacopoeia, 31st edn. Royal Pharmaceutical Society, London... [Pg.342]

The following year, the British National Formulary, a joint publication of the British Medical Association and Royal Pharmaceutical Society of Great Britain (1991), listed suicidal ideation and violent behavior as fluoxetine side effects. Also in 1991,1 published Toxic Psychiatry, in which I observed for the first time that Prozac was producing a continuum of overstimulation that included akathisia, agitation, anxiety, insomnia, depression and mania, and, in the extreme, suicide and violence. I drew on previously sequestered FDA premarketing data on Prozac, the scientific literature, and my own clinical and forensic cases. [Pg.117]

British Medical Association and Royal Pharmaceutical Society of Great Britain. (1991, September). British national formulary (BNF). London Pharmaceutical Press. Brodal, A. (1969). Neurological anatomy. New York Oxford University Press. [Pg.473]


See other pages where Royal Pharmaceutical Society is mentioned: [Pg.94]    [Pg.112]    [Pg.360]    [Pg.730]    [Pg.772]    [Pg.279]    [Pg.392]    [Pg.508]    [Pg.643]    [Pg.295]    [Pg.10]   


SEARCH



Pharmaceutical Society

Royal

Royal Pharmaceutical Society of Great

Royal Pharmaceutical Society of Great Britain

Royal Society

© 2024 chempedia.info